NO146468C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazepin derivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazepin derivater

Info

Publication number
NO146468C
NO146468C NO784235A NO784235A NO146468C NO 146468 C NO146468 C NO 146468C NO 784235 A NO784235 A NO 784235A NO 784235 A NO784235 A NO 784235A NO 146468 C NO146468 C NO 146468C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
benzazepine derivatives
analogy procedure
active benzazepine
Prior art date
Application number
NO784235A
Other languages
English (en)
Norwegian (no)
Other versions
NO146468B (no
NO784235L (no
Inventor
William Edward Bondinell
Robert Grubb Pendleton
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of NO784235L publication Critical patent/NO784235L/no
Publication of NO146468B publication Critical patent/NO146468B/no
Publication of NO146468C publication Critical patent/NO146468C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/58—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO784235A 1977-12-21 1978-12-15 Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazepin derivater NO146468C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86289277A 1977-12-21 1977-12-21

Publications (3)

Publication Number Publication Date
NO784235L NO784235L (no) 1979-06-22
NO146468B NO146468B (no) 1982-06-28
NO146468C true NO146468C (no) 1982-10-06

Family

ID=25339656

Family Applications (1)

Application Number Title Priority Date Filing Date
NO784235A NO146468C (no) 1977-12-21 1978-12-15 Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazepin derivater

Country Status (18)

Country Link
EP (1) EP0002624B1 (de)
JP (1) JPS5488285A (de)
AR (1) AR220361A1 (de)
AT (1) AT367410B (de)
AU (1) AU517619B2 (de)
CA (1) CA1090798A (de)
DE (1) DE2861177D1 (de)
DK (1) DK541078A (de)
ES (1) ES476108A1 (de)
FI (1) FI783838A7 (de)
HU (1) HU177901B (de)
IL (1) IL56237A0 (de)
IT (1) IT1100851B (de)
NO (1) NO146468C (de)
PH (1) PH14063A (de)
PT (1) PT68919A (de)
YU (1) YU303278A (de)
ZA (1) ZA786230B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3001579A1 (de) * 1980-01-17 1981-07-23 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von anthranilsaeurealkylestern
EP0041627B1 (de) * 1980-05-16 1984-08-08 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 3H-2-Benzazepine, Zwischenprodukte und Verfahren zu ihrer Herstellung, sowie diese enthaltende Präparate
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
CA2347095A1 (en) * 1998-10-16 2000-04-27 Takeda Chemical Industries, Ltd. Nitrogen-containing condensed heterocyclic derivatives, their production and agent
CN101258136A (zh) * 2005-07-05 2008-09-03 阿斯利康(瑞典)有限公司 新化合物、其制备方法、中间体、药物组合物和其在治疗5-ht6介导的疾病例如阿尔茨海默病、认知障碍、精神分裂症相关的认知缺损、肥胖和帕金森病中的用途
US7956050B2 (en) 2005-07-15 2011-06-07 Albany Molecular Research, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828096A (en) * 1966-11-22 1974-08-06 Mc Neil Labor Inc 2-alkoxycarbonyl-3-aryl-propylamines

Also Published As

Publication number Publication date
DK541078A (da) 1979-06-22
EP0002624B1 (de) 1981-10-14
YU303278A (en) 1983-06-30
IT1100851B (it) 1985-09-28
FI783838A7 (fi) 1979-06-22
IT7830974A0 (it) 1978-12-18
NO146468B (no) 1982-06-28
AU4265278A (en) 1979-06-28
JPS5488285A (en) 1979-07-13
ATA918878A (de) 1981-11-15
AR220361A1 (es) 1980-10-31
PH14063A (en) 1981-01-26
DE2861177D1 (en) 1981-12-24
AT367410B (de) 1982-07-12
ES476108A1 (es) 1979-11-16
NO784235L (no) 1979-06-22
AU517619B2 (en) 1981-08-13
IL56237A0 (en) 1979-03-12
ZA786230B (en) 1979-10-31
PT68919A (en) 1979-01-01
HU177901B (en) 1982-01-28
EP0002624A1 (de) 1979-06-27
CA1090798A (en) 1980-12-02

Similar Documents

Publication Publication Date Title
NO150800C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tricykliske forbindelser
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO157817C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO149923C (no) Analogifremgangsmaate for fremstlling av fysiologisk aktive prolinderivater
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO150360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO149065C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
NO781824L (no) Fremgangsmaate ved fremstilling av analgesisk aktive forbindelser
NO784393L (no) Fremgangsmaate ved fremstilling av anti-allergisk aktive pyrimidin-derivater
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO148455C (no) Fremgangsmaate ved fremstilling av diazepin-derivater
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149737C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO148451C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oximethere
NO171501C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO167027C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazodiazepinderivater
NO149960C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater
NO152172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater